WASHINGTON (dpa-AFX) – Thermo Fisher Scientific Inc. (TMO) announced Thursday that it has entered into a definitive agreement to acquire CorEvitas, LLC from Audax Private Equity for $912.5 million in cash. Waltham, Massachusetts -based CorEvitas provides regulatory-grade, real-world evidence for approved medical treatments and therapies. The transaction is expected to…Read More
Thermo Fisher Scientific To Buy CorEvitas In 9125 Mln Cash Deal
